-transparent.png){kind=logo}
First-time abciximab administration was associated with acute profound thrombocytopenia in 4 of 575 consecutive patients. Therapy with platelet transfusion, but not intravenous immunoglobulin, was associated with a rapid and sustained increment in circulating platelet count and clinical hemostasis.
Related Publications
D J Kereiakes, and
J H Essell, and
C W Abbottsmith, and
T M Broderick, and
J P Runyon
January 2000,
The Annals of pharmacotherapy,
D J Kereiakes, and
J H Essell, and
C W Abbottsmith, and
T M Broderick, and
J P Runyon
September 2004,
Heart (British Cardiac Society),
D J Kereiakes, and
J H Essell, and
C W Abbottsmith, and
T M Broderick, and
J P Runyon
March 1998,
Circulation,
D J Kereiakes, and
J H Essell, and
C W Abbottsmith, and
T M Broderick, and
J P Runyon
February 1997,
Circulation,
D J Kereiakes, and
J H Essell, and
C W Abbottsmith, and
T M Broderick, and
J P Runyon
February 2011,
The Journal of invasive cardiology,
D J Kereiakes, and
J H Essell, and
C W Abbottsmith, and
T M Broderick, and
J P Runyon
January 2001,
Cardiology,
D J Kereiakes, and
J H Essell, and
C W Abbottsmith, and
T M Broderick, and
J P Runyon
November 1998,
Clinical cardiology,
D J Kereiakes, and
J H Essell, and
C W Abbottsmith, and
T M Broderick, and
J P Runyon
January 2011,
Archivos de cardiologia de Mexico,
D J Kereiakes, and
J H Essell, and
C W Abbottsmith, and
T M Broderick, and
J P Runyon
October 2014,
Minnesota medicine,
D J Kereiakes, and
J H Essell, and
C W Abbottsmith, and
T M Broderick, and
J P Runyon
April 2001,
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions,
